secwatch.observer — SEC 8-K summary
======================================

Issuer:     HCA Healthcare, Inc. (HCA)
CIK:        0000860730
Form:       8-K
Filed at:   2024-07-23T23:59:59+00:00
Accession:  0001193125-24-182591
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HCA Q2 2024 rev $17.49B, EPS $5.53, raises FY guidance
------------------------------------------------------

- Revenue $17.492B (+10.3% YoY); net income $1.461B ($5.53 diluted EPS) vs $1.193B ($4.29).
- Adjusted EBITDA $3.550B (+16.2% YoY); same facility admissions +5.8%, ER visits +5.5%.
- FY2024 guidance raised: rev $69.75-71.75B (prev $67.75-70.25B), EPS $21.60-22.80 (prev $19.70-21.20).
- Board declared quarterly dividend $0.66/share, payable Sept 30, record Sept 16.
- Repurchased 4.217M shares at $1.367B in Q2; $4.228B remaining under buyback authorization.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/860730/000119312524182591/0001193125-24-182591-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/860730/000119312524182591/d873924d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-182591

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer